The Singh study used the same method and the Levy study used a very similar culturing method.
But we already know that neither Singh or Levy used the same methodology as the WPI.
And if they both did culture (can't remember the details) then they didn't culture for anywhere near the same number of days as Judy Mikovits.
But that doesn't matter anyway, if they didn't replicate all of the other variables.
I don't see why, contamination with an infectious virus can account for all the WPI results. The fact that they use cells that have been found to be infected in other labs (LnCAP) and the VP62 construct could account for the findings.
Yes, contamination would be a simple answer, but not necessarily the correct answer.
Anyway, we've already rehearsed all of the arguments, so I'm not going to repeat them again.
Have you not thought about XMRV infection in all of those substrates, and how XMRV appears to have so easily contaminated so many labs?
How would they possibly have avoided contamination of vaccine substrates with XMRV? Especially as they don't even seem to have been testing for it up until now.
And what happens once XMRV is inside the human body?
It becomes
latent. (
i.e. very difficult to detect.)
There's a lot more work to be done.
Did you say that not many labs have detected XMRV? That's not true. Quite a number of researchers have found XMRV in prostate cancer, including Switzer at the CDC. And in Singh's case, she has also found it in breast cancer samples.
Dr Singh has also detected XMRV in the healthy population (at the same rate as the WPI) but only in tissue, not blood.
Switzer could also detect XMRV in tissue but not in blood.
Does this not lead you to ask questions, with your scientifically curious mind, rather than draw early conclusions?